This inventor holds 24 USPTO granted patents and 1 published patent application, primarily in Cell Encapsulation Technology. Top assignees: Cytotherapeutics, Inc., Brown University, Harvard College. Active years: 1991-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Waltham, MA (US) (1991)
- Mansfield, MA (US) (1994 - 2023)
Company Filing History:
10 out of 32 
9 out of 492 
2 out of 3,075 
Years Active: 1991-2023
Areas of Expertise:
Title: Edward J. Doherty: Innovator in Pathogen Vaccines
Introduction
Edward J. Doherty, a notable inventor based in Mansfield, MA, has made significant contributions to the field of vaccine development. With a total of 24 patents to his name, he has been pivotal in innovating solutions for pathogen-related infections.
Latest Patents
One of his latest patents focuses on "Pathogen vaccines and methods of producing and using the same." This invention provides advanced vaccine compositions and detailed methods for producing them. It outlines various embodiments, including methods for treating pathogen infections, vaccinating subjects against these infections, and addressing antibiotic-resistant bacterial infections. Additionally, the invention includes strategies for reducing pathogen levels in infected subjects, improving survival rates, and alleviating pain and distress associated with infections. Novel scaffold compositions, along with opsonin-bound or lectin-bound pathogen compositions, are also key components of this groundbreaking work.
Career Highlights
Edward J. Doherty's career has been marked by his association with key research entities. He has worked with Cytotherapeutics, Inc., and the Brown University Research Foundation, contributing his expertise in vaccine technology and infection treatment. His innovations continue to play a crucial role in advancing medical science and enhancing public health.
Collaborations
Throughout his career, Doherty has collaborated with notable colleagues, including Brian M. Cain and Frank T. Gentile. These partnerships have likely fostered an environment of innovation and discovery, paving the way for advancements in vaccine research.
Conclusion
In summary, Edward J. Doherty stands as a prominent figure in the field of vaccine innovation. His impressive patent portfolio and collaborative efforts reflect a deep commitment to addressing critical health challenges posed by pathogens. As vaccine technology continues to evolve, his contributions will undoubtedly leave a lasting impact on the medical community and public health initiatives.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile